These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 9359726

  • 41. [Randomized study of cefatrizine versus cefaclor in conjunctivitis otitis syndrome].
    Cohen R, de la Rocque F, Bouhanna A, Boucherat M, Elbez A, Lecompte MD, Wollner A.
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):517-20. PubMed ID: 2200994
    [Abstract] [Full Text] [Related]

  • 42. Microbiology of bacteria causing recurrent acute otitis media (AOM) and AOM treatment failure in young children in Spain: shifting pathogens in the post-pneumococcal conjugate vaccination era.
    Pumarola F, Marès J, Losada I, Minguella I, Moraga F, Tarragó D, Aguilera U, Casanovas JM, Gadea G, Trías E, Cenoz S, Sistiaga A, García-Corbeira P, Pirçon JY, Marano C, Hausdorff WP.
    Int J Pediatr Otorhinolaryngol; 2013 Aug; 77(8):1231-6. PubMed ID: 23746414
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Use of oral cephalosporins in the treatment of acute otitis media in children.
    Brook I.
    Int J Antimicrob Agents; 2004 Jul; 24(1):18-23. PubMed ID: 15225855
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
    Seral C, Suárez L, Rubio-Calvo C, Gómez-Lus R, Gimeno M, Coronel P, Durán E, Becerril R, Oca M, Castillo FJ.
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733
    [Abstract] [Full Text] [Related]

  • 53. In-vitro activity of cefprozil (BMY 28100) and loracarbef (LY 163892) against pathogens obtained from middle ear fluid.
    Arguedas AG, Arrieta AC, Stutman HR, Akaniro JC, Marks MI.
    J Antimicrob Chemother; 1991 Mar; 27(3):311-8. PubMed ID: 1903788
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. [Clinical isolates and treatment of acute otitis media].
    Kataoka S.
    Jpn J Antibiot; 2001 May; 54 Suppl B():30-3. PubMed ID: 12638139
    [No Abstract] [Full Text] [Related]

  • 56. Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections.
    Schleupner CJ, Anthony WC, Tan J, File TM, Lifland P, Craig W, Vogelman B.
    Arch Intern Med; 1988 Feb; 148(2):343-8. PubMed ID: 3277562
    [Abstract] [Full Text] [Related]

  • 57. Randomized controlled study of clarithromycin versus cefaclor suspensions in the treatment of acute otitis media in children.
    Pavlopoulou J, Leotsacos P, Sereti E, Anastasiou A, Syriopoulou V.
    J Chemother; 1995 Nov; 7 Suppl 4():150-3. PubMed ID: 8904139
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Double-blind comparison of cefixime and cefaclor in the treatment of acute otitis media in children.
    Piippo T, Stefansson S, Pitkäjärvi T, Lundberg C.
    Scand J Infect Dis; 1991 Nov; 23(4):459-65. PubMed ID: 1957129
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.